Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Life & the LawAbortion Drugs Issues in Law & Medicine

United Kingdom Data Deficiencies Influencing U.S. FDA Decisions

Additional authors: Calum Miller, MD and Kevin Duffy, MPH

 

Abstract

The U.S. FDA has permanently removed the in-person prescribing requirements that previously safeguarded the use of mifepristone/misoprostol medical abortions, allowing prescribing through telemedicine or on-line ordering and distribution through the mail and pharmacies, without standard pre-abortion testing. This will increase the risk of complications due to failure to adequately determine the gestational age or rule out ectopic pregnancy by ultrasound or physical exam, failure to perform labs to document whether RhoGAM is indicated, and failure to obtain appropriate informed consent to prevent unwanted abortions, among other concerns. The FDA justified this action by referencing flawed studies with significantly undercounted complications. The details of these study deficiencies are examined in this paper.

Read Complete Article

Latest Posts

April 14, 2026 An orange pill bottle, scattered white pills, and an ultrasound photo strip rest on a textured pink fabric surface, symbolizing the experience of a medical abortion. Drug-induced Abortion After the First Trimester April 10, 2026 White capsules spilling from an open white paper package onto a wooden surface, with several capsules scattered above the package—an image evoking the ongoing debate over America’s abortion law. Abortion Law in America Today: Confronting Infringements on Pro-life Laws April 9, 2026 A woman with dark hair wearing a dark t-shirt sits against a light-colored wall, looking downcast and thoughtful, perhaps reflecting on the psychological reactions many women experience after an abortion, her face set in a neutral expression. New Study: Most Women Seeking Abortion Have Higher Risk of Negative Psychological Reactions

You Might Also Be Interested In

White capsules spilling from an open white paper package onto a wooden surface, with several capsules scattered above the package—an image evoking the ongoing debate over America’s abortion law.

Abortion Law in America Today: Confronting Infringements on Pro-life Laws

April 10, 2026
Please login to bookmark Close

Fact Sheet: Health Insurance Coverage of Elective Abortion

charlotte-lozier-institute Charlotte Lozier Institute
March 31, 2026
Please login to bookmark Close

Are Pro-Life Laws Harming Iowa Women? An Examination of Claims Against Iowa

March 26, 2026
Please login to bookmark Close

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image